ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 128 filers reported holding ZS PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $62,530,000 | +58.3% | 952,337 | +26.3% | 0.02% | +77.8% |
| Q2 2015 | $39,493,000 | +114.7% | 753,828 | +72.5% | 0.01% | +125.0% |
| Q1 2015 | $18,391,000 | +6.5% | 437,054 | +5.2% | 0.00% | 0.0% |
| Q4 2014 | $17,267,000 | +189.7% | 415,370 | +173.4% | 0.00% | +100.0% |
| Q3 2014 | $5,961,000 | – | 151,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 2,576,723 | $169,188,000 | 84.73% |
| DAFNA Capital Management LLC | 66,194 | $4,346,000 | 4.31% |
| Opaleye Management Inc. | 95,000 | $6,238,000 | 3.07% |
| Redmile Group, LLC | 514,107 | $33,756,000 | 2.56% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,002,444 | $65,820,000 | 1.41% |
| MAZAMA CAPITAL MANAGEMENT INC | 76,779 | $5,041,000 | 1.05% |
| Kerrisdale Advisers, LLC | 45,021 | $2,956,000 | 0.86% |
| Rock Springs Capital Management LP | 155,000 | $10,177,000 | 0.83% |
| USS Investment Management Ltd | 590,396 | $38,765,000 | 0.69% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 21,479 | $1,410,000 | 0.67% |